ArticleeLife2023

Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study.

Barnaby Flower et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.